================================================================================
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
August 13, 2004
TRANSGENOMIC, INC.
(Exact name of registrant as specified in its charter)
Delaware 000-30975
(State of Formation) (Commission File Number)
911789357
(IRS Employer Identification Number)
12325 Emmet Street
Omaha, NE 68164
(Address of principal executive offices) (Zip Code)
(402) 452-5400
(Registrants' telephone number, including area code)
Not applicable
(Former name or former address, if changed since last report)
================================================================================
Item 5. Other Events and Regulation FD Disclosure.
On August 12, 2004, the Company issued a press release announcing results
of operations and summary financial position for the quarter ended June 30,
2004. A copy of the press release is filed herewith as Exhibit 99.1 and is
incorporated herein by reference.
Item 7. Financial Statements and Exhibits.
(c) Exhibits
99.1 Press Release, dated August 12, 2004, announcing the second quarter
results of operations and summary financial position for the
registrant's quarter ended June 30, 2004.
Item 12. Results of Operations and Financial Condition.
On August 12, 2004, Transgenomic, Inc. (the "Company") issued a press
release announcing results of operations and summary financial position for the
quarter ended June 30, 2004. The Company is attaching the press release as
Exhibit 99.1 to this Current Report on Form 8-K.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
TRANSGENOMIC, INC.
By /s/ Mitchell L. Murphy
--------------------------------------
Mitchell L. Murphy, Vice President,
Secretary & Treasurer
August 13, 2004